Results 1 to 10 of about 1,671 (202)

Physiological significance of antithrombin D-helix interaction with vascular GAGs. [PDF]

Blood Adv
Biswas I, Panicker SR, Lupu F, Rezaie AR.   +3 more
europepmc   +1 more source

Dynamics of coagulation proteins upon ICU admission and after one year of recovery from COVID-19: a preliminary study. [PDF]

Front Cell Infect Microbiol
Behar-Lagares R, Virseda-Berdices A, Martínez-González Ó, Blancas R, Homez-Guzmán M, Manteiga E, Churruca-Sarasqueta J, Manso-Álvarez M, Algaba Á, Resino S, Fernández-Rodríguez A, Jiménez-Sousa MA.   +11 more
europepmc   +1 more source

Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference. [PDF]

Pediatr Crit Care Med
Zantek ND, Steiner ME, Teruya J, Kreuziger LB, Raffini L, Muszynski JA, Alexander PMA, Gehred A, Lyman E, Watt K, Pediatric ECMO Anticoagulation CollaborativE (PEACE), in collaboration with the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, the Pediatric Critical Care Blood Research Network (BloodNet), and the Pediatric ECMO subgroup of PALISI and the Extracorporeal Life Support Organization (PediECMO).   +13 more
europepmc   +1 more source

The transition of the criteria for disseminated intravascular coagulation and the targeted patients in randomized controlled trials over the decades: a scoping review. [PDF]

Thromb J
Matsuoka T, Yamakawa K, Umemura Y, Homma K, Iba T, Sasaki J.   +5 more
europepmc   +1 more source

Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials. [PDF]

Thromb J
Wang Q, Wu J, Tang W, Zhang H.
europepmc   +1 more source

Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article. [PDF]

Cardiovasc Ther
Wang G, Qi K, Li X, Zuo S, Zhang R, Zhao Y, Sun S, Zhang J, Liu X.   +8 more
europepmc   +1 more source

Dabigatran-related Nephropathy Complicated by Tubulointerstitial Nephritis in a Patient with a Normal Renal Function and Undiagnosed IgA Nephropathy. [PDF]

Intern Med
Iwafuchi Y, Ito Y, Imai N, Oyama Y, Narita I.   +4 more
europepmc   +1 more source

THE INTERACTION BETWEEN ANTITHROMBIN AND ENDOTHELIAL HEPARAN SULFATE MITIGATES PULMONARY THROMBOINFLAMMATION AFTER TRAUMA AND HEMORRHAGIC SHOCK. [PDF]

Shock
Del Pilar Huby Vidaurre M, Mokhtari AK, Osborn BK, Cotton BA, Wang YW, Xu Y, Arnold K, Liu J, Richter JR, Cardenas JC.   +9 more
europepmc   +1 more source

Effect of endothelium on the anticoagulant activity of a covalent antithrombin-heparin complex. [PDF]

Sci Rep
Atkinson HM, Stevic I, Berry LR, Chan AKC.   +3 more
europepmc   +1 more source

Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, “antithrombin III toyama”

Thrombosis Research, 1987
Antithrombin III (AT III) microheterogeneity was investigated in 12 cases of congenital AT III deficiency and 2 cases of congenital AT III abnormality by isoelectric focusing (IEF) and immunofixation. In congenital AT III deficiency, IEF and immunofixation revealed AT III as 8 bands which was indistinguishable from normal control in terms of the number
N, Sakuragawa, S, Kondo, M, Katoh, K, Takahashi, T, Koide   +4 more
openaire   +2 more sources